OM:BIOA B
OM:BIOA BBiotechs

How Leqembi’s China Insurance Listing At BioArctic (OM:BIOA B) Has Changed Its Investment Story

BioArctic’s partner Eisai has announced that Alzheimer’s drug Leqembi (lecanemab) has been added to China’s National Healthcare Security Administration “Commercial Insurance Innovative Drug List,” expanding access to early Alzheimer’s treatment in a key market following its June 2024 launch there. This move materially enhances the commercial potential of Leqembi in China, which could be important for BioArctic given its role in the drug’s development and its ongoing commercialization...
OM:VOLCAR B
OM:VOLCAR BAuto

Is Volvo Car AB (OM:VOLCAR B) Turning Embedded Data Into A Margin Story Or A Cost Sink?

In early December 2025, Volvo Cars reported that November car sales fell to 60,244 units from 66,977 a year earlier, with year-to-date volumes at 634,993 versus 689,585 in the prior period, and an Extraordinary General Meeting elected Pieter Nota and Caroline Grégoire-Sainte-Marie to the Board until the next AGM. Motorq announced a new partnership with Volvo Cars to feed embedded vehicle data into its AI platform for real-time fleet and dealership insights, highlighting Volvo’s push to turn...
OM:SKA B
OM:SKA BConstruction

How Investors Are Reacting To Skanska (OM:SKA B) Winning a US$368 Million US Data Center Deal

Skanska announced it has secured two additional contracts with a repeat client to build and complete a large data center in Virginia, USA, worth a combined US$368 million (about SEK 3.68 billion), to be booked in its US order intake for the fourth quarter of 2025. These projects deepen Skanska’s role in fast-growing digital infrastructure construction, extending its US data center workload well into 2027 and reinforcing visibility in its order backlog. We’ll now examine how this expanded US...
OM:DIOS
OM:DIOSReal Estate

Exploring 3 Undervalued Small Caps In The European Market With Insider Action

As the European market navigates a complex landscape marked by mixed performances across major indices and a slight uptick in eurozone inflation, small-cap stocks present intriguing opportunities for investors seeking growth potential amid economic fluctuations. In this environment, identifying promising small caps often involves looking at companies with solid fundamentals that can weather economic shifts and leverage insider actions as indicators of confidence.
OM:SECT B
OM:SECT BHealthcare Services

Will New NHS Cloud Wins and Pathology Deal Change Sectra's (OM:SECT B) As-a-Service Narrative?

Sectra recently secured a multi-year deal to provide its Sectra One Cloud enterprise imaging service to four NHS trusts, alongside a 7-year SEK 37.5 MSEK digital pathology contract in Sweden and a new AI-enabled reporting solution launch in the US. Together, these wins highlight how Sectra is deepening long-term, cloud-based relationships across major healthcare systems while layering in workflow and AI tools that can increase customer stickiness. We’ll now examine how expanding Sectra One...
OM:LIME
OM:LIMESoftware

European Stocks Estimated Up To 28.8% Below Intrinsic Value

As the European market navigates mixed returns with hopes of interest rate cuts from major economies, investors are keenly observing opportunities that may arise from undervalued stocks. In this context, identifying stocks trading below their intrinsic value can be a strategic move, as these equities might offer potential for growth when market conditions stabilize.
OM:RUSTA
OM:RUSTAMultiline Retail

European Undervalued Small Caps With Insider Action In December 2025

As the European markets navigate a landscape marked by mixed returns and hopes for interest rate cuts, small-cap stocks are drawing attention amid economic indicators that highlight resilience in sectors like manufacturing and housing. With the pan-European STOXX Europe 600 Index showing modest gains, investors are keenly observing opportunities within smaller companies that may be poised for growth despite broader market uncertainties. Identifying promising small caps often involves looking...
OM:SAND
OM:SANDMachinery

Is Sandvik’s Strong 2025 Share Price Run Still Supported by Fundamentals?

Wondering if Sandvik is still a smart buy after its big run, or if most of the upside is already baked in? Let us unpack what the current price really implies about its future. Sandvik shares have climbed 45.6% year to date and 39.7% over the last year, adding to a strong 67.2% three year and 75.8% five year track record. This comes even as the most recent 7 day and 30 day gains of 2.3% and 2.5% hint at a slower, more measured climb from the last close of SEK 293. Recent moves have been...
OM:BTS B
OM:BTS BProfessional Services

3 European Dividend Stocks To Consider

As European markets navigate mixed returns and hopes for interest rate cuts, investors are paying close attention to economic indicators such as inflation and GDP growth. In this environment, dividend stocks can offer a stable income stream, making them an attractive option for those seeking potential resilience against market volatility.